Chimerism in survivors following allograft renal transplantation.
Lee
J M
JM
Department of Surgery, National Taiwan University Medical Center, Taipei, People's Republic of China.
Lee
C J
CJ
Hu
C Y
CY
Hsieh
R P
RP
Hu
R H
RH
Lee
P H
PH
Luh
S P
SP
Lee
Y C
YC
Chu
S H
SH
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001483:Base Sequence; D002678:Chimera / Q000276:immunology*; D016572:Cyclosporine / Q000627:therapeutic use; D017931:DNA Primers; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival / Q000276:immunology*; D006684:HLA-DR Antigens / Q000032:analysis / Q000235:genetics; D059810:HLA-DR Serological Subtypes; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009035:Mothers; D009679:Nuclear Family; D016133:Polymerase Chain Reaction; D011239:Prednisolone / Q000627:therapeutic use; D014019:Tissue Donors; D014184:Transplantation, Homologous
D017931:DNA Primers; D006684:HLA-DR Antigens; D059810:HLA-DR Serological Subtypes; C080766:HLA-DR11 antigen; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine